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1. Introduction
The present is an exciting time in the field of regenerative biology in dental medicine. Many
basic and clinical studies have been performed to improve periodontal therapy and rehabili‐
tation therapy for morphological and functional recovery of the maxillofacial bones. Many
materials, e.g., hydroxyapatite, GTR membrane, enamel matrix derivative, and platelet-rich
plasma, have been applied to osseous defects to achieve significant outcomes. In contrast, cell
therapy, as an advanced tissue-engineering technology, using bone marrow stem cells,
periosteal cells, or periodontal ligament cells have just been started in several university
hospitals and institutes in Japan.
The periosteum has been recognized as a promising source of immature osteogenic progenitor
cells. Osteogenic cells are important components as a promoter of bone regenerative therapy
because their bioactivities are crucial to reconstituting an active site of controlled bone
formation. We demonstrated that implantation of cultured periosteal sheets into nude mice
could induce the formation of bone-like tissue [Kawase et al., 2009]. In addition, we established
regenerative surgery with autologous cultured periosteal sheets in combination with platelet-
rich plasma (PRP) and hydroxyapatite (HA) in periodontitis patients (Fig. 1) [Yamamiya et
al., 2008, Okuda et al.,2013]. Furthermore, we reported remarkable bone remodeling in reduced
alveolar bone from autologous bone grafting with cultured periosteal sheets [Nagata et al.,
2012].
In this chapter, we will introduce the characteristics of periosteal sheets and clinical outcome
by cell-based therapy in patients with periodontitis and alveolar jaw reduction. In addition,
future perspectives on regenerative therapy will be described.
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 1. Cultured periosteal sheet application to infrabony defects in patients with periodontitis
2. Biological characteristics of the cultured periosteal sheet
Our periosteal sheets are prepared using static explant cultures of small pieces of alveolar
periosteum tissue. The number of cells can be expanded at least by 1000 times by the end of
the 6-week preparation, and the resulting periosteal sheet is mechanically tough enough to be
picked up by forceps [Kawase et al., 2009]. In our experience preparing more than 2000
periosteal sheets, we confirmed that the growth is not significantly dependent either on age
or sex. The successful preparation is rather dependent on the cell density in excised periosteum
tissue segments. It is also important to handle the excised periosteum tissue in a timely manner,
especially in the initial preparation of the “cut and paste” onto culture dishes because this
procedure includes a time-sensitive semi-drying process for facilitating tissue segment
attachment onto the plastic surface.
We developed this grafting material as a substitute for crushed autologous bone, a gold
standard osteogenic grafting material. Therefore, the periosteal sheets are expected to express
osteogenic and osteoinductive capabilities besides (or rather than) the osteoconductive
capability displayed by most recent bone filler made of bioactive ceramics.
In our basic studies using in vitro cell culture systems and in vivo animal implantation systems,
we have demonstrated several remarkable characteristics of the periosteal sheet, which are
summarized below:
Tissue-like thickness: The periosteal sheet displays a unique structure that is composed of
cell-multilayers and abundantly deposited extracellular matrices (ECM).
Osteogenicity: Periosteal cells within the periosteal sheet differentiate to osteogenic cells
slowly but spontaneously with time of expansion using a conventional medium.
Osteoinduction: The periosteal sheet produces the major growth factors involved in bone
metabolism.




Because of the cell-multilayered structure, as shown in Figure 2 (Left), the periosteal sheet is
substantially thicker than a monolayer cell sheet [Kawase et al., 2009]. In addition, the thickness
of the periosteal sheet can be enhanced by many types of commercially available stem-cell
culture media [Uematsu et al., 2013a, 2013b] (Fig. 2 Right). However, intact periosteum tissue
is hardly excised for expansion culture, and the native periosteum-like structure, dual-layers
composed of the cambium and fibrous layers, could not be newly formed or regenerated in
vitro under our static culture expansion conditions.
Figure 2. Effects of culture media on the morphology of periosteal sheets.
Periosteal sheets were expanded with the conventional growth medium (Medium 199
supplemented with 10% FBS) or a commercial stem-cell medium (MesenCult) for 35 days.
Saggital paraffin sections were stained with hematoxylin & eosin.
Interestingly, as far as we could attempt and achieve, similar cell-multilayered structures can
barely be formed by similar expansion cultures of other connective tissues, such as epidermal
and periodontal ligament tissue [Kawase et al., Unpublished observations]. It is also impossible
to form similar structures using dispersed single periosteal cell populations in conventional
two-dimensional (2D) culture systems. However, using appropriate scaffolding materials, we
developed a 3D culture system for preparation of similar periosteal sheets [Kawase et al., 2014].
Material Region Stiffness n
Periosteal sheet central 5.59 ± 3.24 kPa 76
Periosteal sheet peripheral 4.35 ± 2.69 kPa 63
Dispersed periosteal cells 14.3 ± 9.42 kPa 118
Dispersed periosteal cells
(living) 9.04 ± 9.20 kPa 54
Tissue culture polystyrene 2.34 ± 1.54 GPa 79
Stiffness was evaluated by the nanoindentation technique using an atomic force microscopy.
Table 1. The apparent stiffness of periosteal sheets.
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On the other hand, from a biomechanical point of view, ECM-enriched structures function as
a soft scaffolding material for proliferating periosteal cells. As shown in Table 1, the stiffness
of a conventional plastic dish is several GPa, whereas that of a light-fixed periosteal sheet is
4-6 kPa [Horimizu et al., 2013]. Because stiffer materials are in general more suitable for cell
mitosis and proliferation [Vincent et al., 2013], it can be predicted that conventional culture
dishes provide more preferable places for periosteal cells to proliferate. This is most likely a
major reason why dispersed periosteal cells grow faster than cells contained in a periosteal
sheet. It has also been reported that the optical stiffness for the osteoblastic differentiation is
25-40 kPa, and softer material surfaces maintain cells in the osteoblast lineage at immature
stages [Engler et al., 2006]. Therefore, it is presumable that a thicker periosteal sheet could be
suitable for the expansion of immature osteoprogenitor cells without inducing the osteoblastic
differentiation.
2.2. Osteogenicity
As a promising osteogenic grafting material, a periosteal sheet should produce mineral
deposits in vitro and form bone-like tissue in vivo. In conventional growth medium, Medium
199 supplemented with 10% fetal bovine serum (FBS), periosteal cells gradually and increas‐
ingly express alkaline phosphatase (ALP) with expansion time [Kawase et al., 2009]. The
addition of chemical agents involved in osteoblastic differentiation, such as dexamethasone,
β-glycerophosphate, and ascorbate, immediately increases ALP activity and simultaneously
mineral deposit formation [Kawase et al., 2009, 2010, 2011].
When implanted into the subcutaneous tissue of nude mice, these periosteal sheets, regardless
of their differentiation stages, are capable of forming osteoid and bone-like tissue more
potently than dispersed periosteal cells combined with porous hydroxyapatite blocks [Kawase
et al., 2009, Uematsu et al., 2013a]. In addition, several periosteal cells, especially those embed‐
ded in dense collagen matrices, become osteocyte-like cells. These data suggest the “osteoge‐
nicity” of the periosteal sheet.
2.3. Osteoinduction
We have detected major growth factors, such as several interleukins, FGF-2 (fibroblast growth
factor-2), MCP-1 (monocyte chemotactic protein-1), TPO (thrombopoeitin), IGFBP-2 (insulin-
like growth factor binding protein-2), GRO (growth-related oncogene) and VEGF (vascular
endothelial growth factor) in conditioned media of the periosteal sheet [Kawase et al., 2009,
Kobayashi et al., Manuscript in submission]. The osteogenic induction using chemical agents
drastically changed the profile of cytokine release, as shown in Table 2.
Following implantation of periosteal sheets into the subcutaneous tissue of nude mice, global
DNA microarray analyses demonstrated that the periosteal sheet influences the surrounding
host tissue and induces osteoclastic phenotypes (Table 3). We also observed that the osteo‐
blastic phenotypes could be induced by the implanted periosteal sheet. In addition, the
osteoinduced periosteal sheet is potently capable of inducing angiogenesis and osteoclastic
formation. Therefore, these data suggest “osteoinduction” by the periosteal sheet.





Osteoblast RUNX2, SatB2, Osteoprotegerin, BMP1, TGFβ1, integrin α5β1, ICAM1





Osteoblast MSX2, ALP, BMP4, Bone gla protein, IGF2
Osteoclast CSF1
The human periosteal sheets, which were implanted into the subcutaneous tissue of nude mice, were retrieved along
with the surrounding mouse tissue. Mouse-specific mRNAs expressed in the surrounding tissue were evaluated by an
Agilent Mouse Genome (4 x 44K) microarray.
Table 3. Global DNA microarray analyses of gene expression in the surrounding mouse connective tissue.
2.4. Conclusion
We should again emphasize that the periosteal sheet is characterized by its unique structure.
Dispersed periosteal cells and other cells in the osteoblast lineage expanded in 2D culture
systems are capable of producing growth factors involved in bone metabolism and forming
mineral deposits as well as the periosteal sheet. However, these cells require appropriate
scaffolding materials for implantation. In addition, a 3D culture system without using
appropriate scaffolding materials, such as accumulation of cell sheets and large-scale spheroid
Changes Growth factors
control > differentiated
moderate IL-6 MCP-1, TPO
control < differentiated
moderate GRO-α, IL-8, IL-13, IGFBP-2
substantial GRO, IL-5, IL-7, IL-10, MCP-3
Growth factors released by the control and the osteoinduced periosteal sheets to the low-serum culture medium were
semi-quantitatively evaluated using an antibody array.
Table 2. Effects of the osteoinduction on the growth factor production by the periosteal sheet.
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formations, typically induces cell necrosis in the central regions. Abundant ECM functions as
a scaffolding material and avoids the increase in cell density, preventing inevitable necrosis.
3. Application of cultured periosteal sheet for periodontal regeneration
To regenerate periodontal tissue destroyed by chronic periodontitis, human autologous
cultured periosteal sheets in combination with platelet-rich plasma (PRP) [Okuda et al., 2003]
and hydroxyapatite (HA) granules, were clinically applied. The periosteum specimens were
dissected from each patient and were incubated for approximately six weeks until the sheets
were formed. Prior to placement of the cultured periosteal sheets, osseous defects were
thoroughly debrided and filled with HA granules in combination with PRP. Standardized
clinical and radiographic measurements were performed during follow-up examinations at
one and five years. Clinical attachment level (CAL) and radiographic infrabony defect depth
(IBD) were determined as the primary and secondary end-points.
The one-year results of this treatment indicate favorable clinical results, when compared to
baseline or when compared to the control group (PRP with HA). A five-year follow-up
evaluation of 22 selected patients after cultured periosteal sheets treatment indicated the
treated infrabony defects remained clinically stable and were well maintained. Radiographi‐
cally, there was increased osseous radiopacity and bone trabeculation, suggesting further bone
maturation.
A factor likely contributing to these favorable clinical results is the presence of osteogenic cells
in the cultured periosteal sheets, which provided greater regeneration potential.
3.1. Case presentation
In this case report, clinical and radiographic evaluation of the clinically representative case #22
of a cultured periosteal sheet in combination with a PRP and HA granule mixture surgically
treated site is presented in Figure 3.
A 56-year-old Japanese female presented with clinical and radiographic (Fig. 3A) evidence of
chronic periodontitis and bone loss on the mesial surface of the mandibular left first molar. At
baseline, the PD was 6 mm, and the CAL was 6 mm. Upon surgical exposure, a 5-mm occlusal-
apical by 5-mm mesio-distal three-walled infrabony osseous defect was revealed on the mesial
surface of the molar (Fig. 3B). After debridement and thorough root planing, a PRP and HA
granule complex was placed into the osseous infrabony defect (Fig. 3C) and overlaid with a
cultured periosteal sheet (Fig. 3D).
At 1-year post-surgery, the PD and CAL were 3 mm and 5 mm, respectively, representing a 1-
mm gain in CAL from baseline, and this favorable clinical response in the decrease of PD and
gain in CAL was maintained at 5 years (Fig. 3E). Increased radiopacity was demonstrated on
the mesial surface of the molar at 1 year and 5 years (Fig. 3F) [Okuda et al., 2009, 2013].
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3.2. Case-controlled clinical trial
Thirty interproximal infrabony osseous defects in 30 healthy, non-smoking subjects diagnosed
with chronic periodontitis were included in this study with one infrabony defect with PD ≥ 6
mm, CAL ≥ 6 mm, and an osseous defect depth estimated to be ≥3 mm when measured
radiographically. The subjects were randomly assigned to a test group (cultured periosteal
sheets combined with PRP and HA) or a control group (PRP with HA). Clinical and radio‐
graphic measurements were performed at baseline and the 1-year post-surgical evaluation.
Compared to baseline, the 1-year results indicated that both treatment modalities resulted in
significant changes (P < 0.01) in the probing depth, clinical attachment level, and radiographic
infrabony defect depth. Compared to the control group, the test group exhibited a significantly
more favorable change in clinical attachment (4.1 ± 1.2 mm versus 5.3 ± 1.5 mm; P < 0.05) and
radiographic infrabony defect (0.4 ± 0.9 mm versus 1.7 ± 1.2 mm; P < 0.01), as shown in Table
4 [Okuda et al., 2005, Yamamiya et al., 2008].
Figure 3. Clinical and radiographic appearance during follow-up examinations at baseline and five years. A: Surgical
area before surgery with IBD depicting 5 mm of bone loss, B: Reflection and debridement of the area revealed a three-
walled osseous defect, C: Grafting with PRP+HA granules, D: The surgical site following placement of the cultured per‐
iosteal sheet covering the PRP+HA granules, E: Clinical view at 5-year follow-up, F: Radiographs at 5 years showing
that the cortical bony architecture and periodontal ligament space appear normal.
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Clinical and Radiographic Index
and Treatment Group Baseline 1-year P value*
PD (mm)
Periosteal sheet + PRP + HA (Test) 7.7 ± 1.1 2.9 ± 0.4 P < 0.01
PRP + HA (Control) 7.6 ± 1.1 3.3 ± 1.0 P < 0.01
P value† NS NS
CAL (mm)
Periosteal sheet + PRP + HA 8.1 ± 1.2 4.1 ± 1.2 P < 0.01
PRP + HA 8.0 ± 1.3 5.3 ± 1.5 P < 0.01
P value NS P < 0.05
IBD (mm)
Periosteal sheet + PRP + HA 5.3 ± 1.1 0.4 ± 0.9 P < 0.01
PRP + HA 4.9 ± 1.4 1.7 ± 1.2 P < 0.01
P value NS P < 0.01
Means ± SD (n=15 subjects in each treatment group). SD=standard deviation. NS=not significant, P > 0.05, * The
significance level between baseline and 1-year, † Statistical significance level between the study groups at baseline or 1-
year.
Table 4. Mean clinical and radiographic measurements at baseline and 1 year for the test (periosteal sheet+PRP+HA)
and control (PRP+HA) study groups.
3.3. Five-year follow-up study
Twenty-two patients who had received surgery using cultured periosteal sheets were included
in the study for statistical analysis comparing the 1-year results and the 5-year follow-up
results. Significant differences between baseline and the 1-and 5-year data were evaluated by
means of the Wilcoxon signed-rank matched-pair test, taking into account the paired nature
of the observations. The mean PD, CAL and IBD scores at baseline are as follows: PD, 7.6 ± 1.4
mm; CAL, 8.0 ± 1.4 mm and IBD, 4.6 ± 1.4 mm (Table 5).
The 1-year results after treatment indicated the mean PD, CAL and IBD values were improved
significantly as compared with baseline (PD: 2.9 ± 0.4 mm at 1-year versus 7.6 ± 1.4 mm at
baseline, P < 0.01; CAL: 4.8 ± 1.4 mm at 1-year versus 8.0 ± 1.4 mm at baseline, P < 0.01; IBD:
1.4 ± 1.1 mm at 1-year versus 4.6 ± 1.0 mm at baseline, P < 0.01).
At the 5-year follow-up, as compared to the 1-year evaluation period, the mean PD and CAL
were stable (PD: 2.9 ± 0.3 mm at 5-years vs. 2.9 ± 0.4 mm at 1 year, NS, CAL: 4.6 ± 1.2 mm at 5-
year vs. 4.8 ± 1.4 mm at 1-year; NS), and IBD was improved significantly when compared to
the 1-year result (0.2 ± 0.5 mm at 5-years vs. 1.4 ± 1.1 mm at 1-year, P < 0.01). It is also noteworthy
that there were no infectious episodes and no other adverse complications associated with
treatment over the five-year time period of this study [Okuda et al., 2013].
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Baseline 1-year 5-years p value
1 vs BL* 5 vs BL† 5 vs 1‡
Clinical Parameter
PD 7.6 ± 1.4 2.9 ± 0.4 2.9 ± 0.3 P < 0.01 P < 0.01 NS
CAL 8.0 ± 1.4 4.8 ± 1.4 4.6 ± 1.2 P < 0.01 P < 0.01 NS
IBD 4.6 ± 1.0 1.4 ± 1.1 0.2 ± 0.5 P < 0.01 P < 0.01 P < 0.01
Means ± SD (n=22 subjects). SD=standard deviation, NS=not significant, P > 0.05, *1 year compared with baseline, †5
year compared with baseline, ‡5 year compared with 1 year
Table 5. Mean clinical and radiographical data at each treated site at baseline and at the 1-and 5-year follow-up
periods.
3.4. Conclusion
Compared to PRP with HA, treatment with a combination of cultured periosteal sheets, PRP,
and HA led to a significantly more favorable clinical improvement in infrabony periodontal
defects at 1-year post-surgery. However, the added benefits of cultured periosteal sheets had
statistical and clinical significance. Once a successful clinical treatment has been achieved with
a combination of cultured periosteal sheets, PRP, and HA granules, the results are maintainable
for 5 years. In addition to the favorable long-term clinical results for treating periodontal
osseous defects, the long-term safety of the cultured periosteal sheets in periodontal therapy
was established.
4. Application of cultured autogenous periosteal cell sheets to alveolar
bone regeneration
Diseases affecting the maxillofacial region often cause defects in alveolar or gnathic bone. The
maxillofacial bones are an important determinant of facial features and play a pivotal role in
mastication and articulation. Thus, rehabilitation therapy helps morphological and functional
recovery of the maxillofacial bones is an important component of the strategies required after
the diseases have been treated. Autogenous bone grafting is the most realistic and effective
method for regenerating bone tissue in defect sites and is therefore widely used. However, the
bone harvesting is accompanied by unavoidable donor site morbidity such as pain and
increased risk of infection.
For these types of reasons, we employed the tissue-engineering approach aided by the
administration of cells derived from autogenous periosteum, which provided osteoblasts
responsible for bone formation and also can promote the recruitment of cells responsible for
bone resorption [Nagata et al., 2012, Uematsu et al., 2013a]. Patients scheduled to undergo
alveolar bone augmentation prior to dental implant placement were subjected to clinical study
of alveolar bone engineering with administration of cultured autogenous periosteal cell
(CAPC) sheet.
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4.1. CAPCs promoted good bone regeneration and reduced the amounts of bone required
for harvesting
CAPCs grafting with autologous bone was performed for alveolar ridge augmentation and for
maxillary sinus lift (Fig. 4). The bone was harvested from the anterior region of the mandibular
ramus in the majority of cases and from the iliac crest in one case. Bone regeneration after
CAPCs grafting with autogenous bone was generally satisfactory, and the predictability of
alveolar bone augmentation was high even in large recipient sites. Use of CAPCs resulted in
alveolar ridge augmentation with satisfactory morphology and long-term stable bone volume
in these advanced cases of atrophy. Furthermore, graft materials containing less than 40% of
the autogenous bone particle also demonstrated good bone formation, and it was found that
using CAPCs was beneficial for the satisfactory formation and long-term maintenance of
regenerated bone. In other words, use of CAPCs can reduce the amount of autogenous bone
required, which reduced donor site morbidity during bone harvesting.
Figure 4. Procedure of autogenous bone grafting with cultured autogenous periosteal cells (CAPCs).
4.2. Recruitment of osteoblasts and osteoclasts to regenerating bone tissue
The histological images of biopsy specimens recovered from the recipient sites at 4 months
after CAPCs grafting with particulated bone exhibit newly formed bone in spaces between the
cortical bone particles in graft material (Fig. 5). Layers of cells strongly immunopositive for
ALP activity were present on the surface of the newly formed bone. Recruitment of TRAP-
positive cells was confirmed for grafted autogenous bone particles and the newly formed bone
(Fig. 5A–H). In clear contrast to these findings, in the biopsy specimens recovered 4 months
after conventional bone grafting, markedly few cells were found around the newly formed
bone, and ALP-positive signals, albeit weak, were found exclusively on the surface of the bone
(Fig. 5I–L). In addition, recruitment of TRAP-positive cells was negligible. These results
indicate that the recruitment of both osteoblasts and osteoclasts to the regenerating bone tissue
is markedly activated at the site of CAPCs grafting with autogenous bone particle, as compared
with that of conventional bone grafting.
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* newly formed bone, g: residual grafted autologous bone particles
Figure 5. Histological analysis of biopsy specimens recovered from the recipient sites at 4 months after bone grafting
with CAPCs (A-H) or conventional bone grafting (I-L). A, C, E (H-E staining) and B, D, F, G, H (ALP-TRAP double stain‐
ing): Active new-bone formation was observed in specimens recovered from the site of a bone graft with CAPCs.
4.3. CAPC-induced bone remodeling after autogenous bone grafting
The volume of newly reformed bone tissue at 1 Y was compared to that at 3 M in the cases of
maxillary sinus lift with autologous bone and CAPCs and in the cases of maxillary sinus lift
with autologous bone only using reconstructed 3D-CT images. Changes in the mean net
volume of augmented bone between the two time points were similar regardless of whether
CAPCs were used. When compared after categorizing the area of augmented bone according
to CT density, the mean volume was 35% lower at 1 Y than at 3 M in the area with a CT density
< 850 HU, regardless of whether CAPCs were used or not (data not shown).
On the other hand, in the high-density area (CT density > 850), marked time-dependent
decreases were found only after bone grafting with CAPCs, whereas no decreases were found
in conventional bone grafting. In color-coded reconstructed 3D-CT images, high CT density
areas believed to correspond to grafted cortical bone particles of mandibular origin contained
in the graft material were almost absent in the 3D-CT images taken at 1 Y after autogenous
bone grafting with CAPCs, but a smooth surface area with high CT density areas was found
on the surface of the augmented bone (Fig. 6). Thus, high-resolution three-dimensional
computed tomography (3D-CT) imaging suggested that remodeling of the grafted autogenous
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cortical bone particles was faster in bone grafting with CAPCs than in conventional bone
grafting.
Figure 6. CT images of the maxillary sinus constructed from DICOM data before surgery and at 3 months (3M) and 1
year (1Y) after CAPC(+) bone graft or conventional CAPC(-) bone grafting. Color mapping of the images according to
bone density as determined by Hounsfield units (HU) for CT data was applied. In the graft material at 3M, many areas
are depicted in light blue (D1) and blue (D2), which is indicative of autogenous cortical bone particles (A and B).
4.4. Conclusions
In this clinical research into CAPC use in bone augmentation, we investigated the effects of
CAPCs on bone regeneration in patients. Augmentation that is difficult to achieve by conven‐
tional autogenous bone grafting, such as that for building bone in both the directions of height
and width in the alveolar ridge or for performing a sinus lift of ≥15 mm in patients with a less
than 2-mm-thick maxillary sinus floor, are feasible through the application of CAPCs,
regardless of age and sex of the patients. The results of histological and 3D-CT analyses suggest
that grafted CAPCs effectively recruited osteoblasts and osteoclasts, thereby simultaneously
promoting bone formation and remodeling.
The effects of CAPCs in regenerative bone therapy may be exerted via various biological
mechanisms, as illustrated in Figure 7. For instance, CAPCs may serve as the original cell
population that gives rise to osteoblasts for bone matrix formation and to constituent cells of
bone tissue such as vascular endothelial cells, as well as serving as a source of various growth
factors, thereby recruiting and activating osteoclasts.
New Trends in Tissue Engineering and Regenerative Medicine - Official Book of the Japanese Society for Regenerative
Medicine
30
Figure 7. Illustration of hypotheses for bone formation and resorption after (A) conventional bone grafting and (B)
after bone grafting with CAPCs.
Bone tissue engineering with CAPC grafting may enable regeneration of bone tissues with
complex morphology in a wide area, and thus, the technique will expand the indications for
regenerative bone therapy. Currently, the autogenous bone content in the graft material has
been reduced to as low as 30% by use of CAPCs. The less invasive approach reduces the burden
on patients and also increases the volume of regenerative bone produced. However, autoge‐
nous bone particles serve as a secure scaffold for bone augmentation and thus are not replace‐
able. The ultimate goal is to establish procedures for CAPC culturing and grafting that enable
regenerative bone therapy without harvesting bone. To achieve this goal, we must continue
working on developing affordable and effective systems for regenerative bone therapy that
also satisfy safety requirements.
5. Future perspectives of cell-based therapy for periodontal and bone
regeneration
5.1. Progress in regenerative therapy for periodontium and maxillofacial bones
First, material-and scaffold-based therapies have been developed using bone replacement
graft and GTR membranes. Second, growth factor application has increased for mixed
components and recombinant proteins. Several approaches involving enamel-matrix deriva‐
tives and PRP/PRF have been reported, and recombinant growth factors (BMP, FGF-2, PDGF,
and GDF-5) have been introduced for periodontal and bone regenerative therapy. Third, cell-
based therapy has recently emerged using bone marrow cells, periosteal cells, and periodontal
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ligament cells. Finally, combination therapy with scaffolds, growth factors, and cells appears
to present a promising strategy to achieve the regeneration of large defects and to enlarge the
indication of therapy [Egusa et al., 2012]. Figure 8 shows already used materials and possible
candidates in the near future for regeneration of periodontium and maxillofacial bones.
5.2. Three challenges for combined cell-based therapy
5.2.1. Biological and clinical safety challenges
Prevention of tumor formation following stem cell implantation is a major safety consideration
from the biological point of view. It is critical to have an understanding of the cell genetic
instability, culture medium and conditions. In addition, practical errors and accidents
involving contamination and infection with virus and mycoplasma should be monitored and
avoided.
Figure 8. Possible biomaterials, proteins, and cells for regeneration of periodontium and maxillofacial bones.
Growth factor GDF: growth differentiation factor, BMP: bone morphogenetic protein, PDGF:
platelet-derived growth factor, FGF: fibroblast growth factor, PRP PRF: platelet-rich plasma
platelet-rich fibrin, EMD: enamel matrix derivative
Scaffolds DFDBA: demineralized freeze-dried bone allograft, FDBA: freeze-dried bone
allograft, DBBM: demineralized bovine bone matrix, HAP: hydroxyapatite, TCP: tricalcium
phosphate, Col: collagen, PLGA: polylactic-polyglycolic acid, PTFE: polytetrafuoroethlene,
GTR: guided tissue regeneration, GBR: guided bone regeneration, 3D: three dimensional
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Cells BMS: bone marrow stem cells, ADPS: adipose stem cells, iPS: induced pluripotent stem
cell, ES: embryonic stem cells
5.2.2. Beneficial technical challenges
It is definitely possible to achieve remarkable regeneration using cell-based therapy compared
with conventional regenerative treatment for satisfaction of patients and cost benefit aspects.
The matrix and scaffold should have good biocompatibility in terms of the cellular and
molecular components during the process of developing and regenerating tissues. The
synergistic effects of cell-based therapy with suitable scaffolds and growth factors are antici‐
pated and should be substantiated in the near future.
5.2.3. Challenges of cell delivery system and cell banking
Cell processing center/room (CPC) is required for cell-based therapy, and the refinement of
techniques to facilitate laboratory handing of cells is also crucial for biological and clinical
applications. CPC should be established at hospital, however, it is impossible to establish CPC.
Thus, a well-controlled cell delivery system is necessary for wide area of several prefectures.
Furthermore, cell banking may be one strategy to realize the potential of cell-based regenera‐
tive therapy. Several types of cells can be cryopreserved to retain regenerative potential. Dental
cells can be isolated from the cryopreserved tissue whenever required for future regenerative
therapies [Chen et al., 2012].
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